PAULINE SUNG: Open Payments
NPI 1205594587 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 38 payments from 18 companies in 2025. Trend: 2023 $991 · 2024 $1,458 · 2025 $1,681
Food & beverage: $1,489Education: $192
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $226 |
| Incyte Corporation | 2 | $224 |
| Daiichi Sankyo Inc. | 7 | $214 |
| PharmaEssentia USA Corporation | 2 | $197 |
| Astellas Pharma US Inc | 4 | $148 |
| Gilead Sciences, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| BeOne Medicines USA, Inc. | 3 | $88 |
| Merck Sharp & Dohme LLC | 1 | $83 |
| ABBVIE INC. | 2 | $49 |
Products named: BESREMI, Enhertu, Monjuvi, Vonjo, CALQUENCE, VENCLEXTA, BRUKINSA, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
